Affordable Access

deepdyve-link
Publisher Website

Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.

Authors
  • Lopez-Soler, Reynold I1
  • Chan, Ryan2
  • Martinolich, Jessica2
  • Park, Lisa3
  • Ata, Ashar2
  • Chandolias, Nikolaos1
  • Conti, David J1
  • 1 Division of Surgery, Section of Transplantation, Albany Medical Center, Albany, NY, USA.
  • 2 Department of Surgery, Albany Medical College, Albany, NY, USA.
  • 3 Department of Surgery, Cleveland Clinic, Cleveland, OH, USA.
Type
Published Article
Journal
Clinical Transplantation
Publisher
Wiley (Blackwell Publishing)
Publication Date
Feb 01, 2017
Volume
31
Issue
2
Identifiers
DOI: 10.1111/ctr.12878
PMID: 27888534
Source
Medline
Keywords
License
Unknown

Abstract

Long-term use of steroids results in predictable secondary effects that can lead to increased morbidity and mortality. In this study, we present 10 years worth of data of early steroid withdrawal (ESW) immunosuppression consisting of mycophenolate, sirolimus, and tacrolimus. From 2003 to 2013, 563 kidney transplant recipients were weaned off steroids prior to discharge. We compared outcomes with that of our 65 historical controls maintained on steroids. We analyzed graft and patient survival and determined the incidence of steroid-related comorbidities such as hypertension, hypercholesterolemia, diabetes, coronary artery disease, and weight gain. Patients on ESW maintenance immunosuppression had improved patient and graft survival compared to controls. (HR: 0.23; P≤.011, 0.57; P=.026). Rates of biopsy-proven acute rejection were not different among both groups (HR: 1.24; P=.610). Incidence of post-transplant diabetes were reduced but not statistically significant (OR: 0.67; P=.138). Additionally, the development of hypertension (OR: 0.86, P≤.01), hypercholesterolemia (RR: 0.82; P=.027), CAD (RR: 0.43; P=.002), and >20 lbs. weight gain (RR: 0.29; P≤.01) was significantly improved over 10 years following initiation of ESW protocols. Early steroid withdrawal in renal transplant recipients results in improved patient and graft survival as well as better rates of post-transplant comorbid conditions.

Report this publication

Statistics

Seen <100 times